638.38美元11(1.69%)
2024/04/25更新
績效 / 1月6.41%
3月8.08%
1年6.02%
晨星評等 - 1.現金1.27%
- 2.股票13.01%
- 3.債券0.00%
- 4.其他85.72%
- 1.美國85.72%
- 2.歐洲不包含歐元區6.70%
- 3.歐元區4.93%
- 4.英國1.37%
- 1.Moderna Inc9.89%
- 2.Vertex Pharmaceuticals Inc9.45%
- 3.Regeneron Pharmaceuticals Inc9.35%
- 4.Alnylam Pharmaceuticals Inc6.92%
- 5.AbbVie Inc4.71%
- 6.Neurocrine Biosciences Inc4.67%
- 7.Genmab A/S4.34%
- 8.Amgen Inc4.22%
- 9.Biohaven Ltd3.46%
- 10.Arrowhead Pharmaceuticals Inc3.34%
- 1.現金1.27%
- 2.股票13.01%
- 3.債券0.00%
- 4.其他85.72%
- 1.美國85.72%
- 2.歐洲不包含歐元區6.70%
- 3.歐元區4.93%
- 4.英國1.37%
- 1.Moderna Inc9.89%
- 2.Vertex Pharmaceuticals Inc9.45%
- 3.Regeneron Pharmaceuticals Inc9.35%
- 4.Alnylam Pharmaceuticals Inc6.92%
- 5.AbbVie Inc4.71%
- 6.Neurocrine Biosciences Inc4.67%
- 7.Genmab A/S4.34%
- 8.Amgen Inc4.22%
- 9.Biohaven Ltd3.46%
- 10.Arrowhead Pharmaceuticals Inc3.34%